Acarbose 50 MG Oral Tablet

INDICATIONS AND USAGE Acarbose tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Mylan Pharmaceuticals Inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] dyspnoea` `[4] diarrhoea` `[5] drug ineffective` `[6] dizziness` `[7] headache` `[8] pain` `[9] asthenia` `[10] off label use`

3 years ago

ROUND WHITE M A 50

HOW SUPPLIED Acarbose Tablets are available containing 25 mg, 50 mg or 100 mg of acarbose, USP. The 25 mg tablets are white to off-white, round, unscored tablets debossed with A over 25 on one side of the tablet and M on the other side. They are available as follows: NDC 0378-2820-77 bottles of 90 tablets The 50 mg tablets are white to off-white, round, unscored tablets debossed with A over 50 on one side of the tablet and M on the other side. They are available as follows: NDC 0378-2821-77 bottles of 90 tablets The 100 mg tablets are white to off-white, round, unscored tablets debossed with A over 100 on one side of the tablet and M on the other side. They are available as follows: NDC 0378-2822-77 bottles of 90 tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture. Dispense in a tight, light-resistant container using a child-resistant closure. Keep container tightly closed. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. REVISED APRIL 2015 ACAR:R3

More pills like ROUND M A 50

Related Pills

Acarbose 25 MG Oral Tablet

Mylan Pharmaceuticals Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site